Current approach to the guidelines for the diagnosis and treatment of osteoarthritis;Osteoartri̇t tani ve tedavi̇ kilavuzlarina güncel bakiş

Turk Geriatri Dergisi

Volumn 14, Issue 2, 2011, Pages 119-125

  Kirazli, Yeşim ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Guideline; Hip; Knee; Osteoarthritis

Indexed keywords

CAPSAICIN; CHONDROITIN SULFATE; CYCLOOXYGENASE 2 INHIBITOR; DIACEREIN; GLUCOSAMINE SULFATE; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

CLINICAL EFFECTIVENESS; DRUG EFFICACY; DRUG SAFETY; HAND OSTEOARTHRITIS; HIP OSTEOARTHRITIS; HUMAN; JOINT EFFUSION; KNEE OSTEOARTHRITIS; KNEE PAIN; OSTEOARTHRITIS; PRACTICE GUIDELINE; REVIEW;

EID: 79960304946     PISSN: 13042947     EISSN: 13079948     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the diagnosis of hand osteoarthritis. Ann Rheum Dis 2009;68:8-17.
2. Zhang W, Doherty M, Peat G, et al. EULAR evidence based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis 2010;69:483-9.
3. Jordan KM, Arden NK, Doherty M, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis. Ann Rheum Dis 2003;62(12):1145-55.
4. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Osteoarthritis and Cartilage 2008;16:137-62.
5. Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis. Ann Rheum Dis 2005;64:669-681.
6. Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis?: a meta-analysis of randomised controlled studies. Ann Rheum Dis 2004;63:901-7.
7. European Medicine Agency Public Statement announces regulatory action on COX-2 inhibitors. Available at http://www.emea.eu.int. Erişim: 17 Şubat 2011.
8. FDA News. FDA announces series of changes to the class of marketed NSAIDs. Available at http://www.fda.gov. Erişim: 20 Mart 2011.
9. Pergolizzi J, Boger RH, Budd K. Opioids and the management of chronic severe pain in the elderly. Pain Pract 2008;8:287-313.
10. Bruyere O, Pavelka K, Rovati LC. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. Menopause 2004;11(2):138-43.
11. Rozendaal RM, Koes BW. Effect of glucosamine on hip osteoarthritis. Ann Intern Med 2008;148: 268-77.
12. Verbruggen G, Goemaere S, Veys EM. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. Clin Rheumatol 2002;21(3):231-43.
13. Uebelhart D, Malaise M, Marcolongo R. Intermittent treatment of knee osteoarthritis with oral chondroidin sulfate: a one year, randomized, double-blind, multicenter study versus plasebo. Osteoarthritis Cart 2004; 12: 269-76.
14. Ernst E. Avocado/soybean unsaponifiables for osteoarthritis-a systematic review. Clin Rheumatol 2003; 22:285-8.
15. Dougados M, Nguyen M, Berdah. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis. Arthritis Rheum 2001;44(11):2539-47.
16. Jubb RW, Piva S, Beinat L. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 KDA sodium hyaluronate on the radiological change in osteoarthritis of the knee. IJCP 2003;57(6):1-8.
17. Arrich J, Piribauer F, Mad P, Schmid D. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: a systematic review and meta-analysis. CMAJ 2005;172(8):1039-44.
18. Gossec L, Dougados M. Intra-articular treatments in osteoarthritis: from the symptomatic to the structure modifying.: Ann Rheum Dis 2004;63:478-82.
19. Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ 2004;328:869.
20. Courtney P, Doherty M. Management of osteoarthritis. International Journal of Advances in Rheumatology 2009; 7(3):73-83.